Gazyva
Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.
What Gazyva Means in Everyday Medical Language
Gazyva is the brand name for the drug obinutuzumab, a type of medicine called a monoclonal antibody. It is designed to target a protein called CD20, which is found on the surface of certain white blood cells known as B cells. Some cancers, like chronic lymphocytic leukemia (CLL) and follicular lymphoma, involve these B cells. By attaching to CD20, Gazyva helps the immune system find and kill these cancer cells.
Why Gazyva Can Matter in Cancer Care
Gazyva is important because it offers a targeted way to treat some blood cancers. Instead of affecting all cells, it focuses on cancer cells with CD20, which can help reduce damage to healthy cells. It is approved to be used with other drugs to treat CLL and follicular lymphoma, especially when other treatments have not worked or as a first treatment in certain cases. This targeted approach can improve how well treatment works and may help patients achieve remission.
What Patients Might See or Hear About Gazyva
If your doctor mentions Gazyva, you might hear it described as a medicine given by infusion that helps the immune system attack cancer cells. You may also see it called obinutuzumab in medical reports or drug information. It is often used alongside chemotherapy drugs like chlorambucil or bendamustine. Patients might be told about possible side effects, such as reactions during infusion or changes in blood counts, and the need for monitoring during treatment.
Where Gazyva Might Appear in Your Care
You could see the term Gazyva or obinutuzumab in your treatment plan, medication list, or lab reports. It may also appear in clinical trial information if you are considering research studies. Because the drug has several names, confirming the exact term with your care team can help avoid confusion.
Common Questions to Ask Your Care Team
When Gazyva is part of your treatment, it’s helpful to ask about how it works with other medicines you are receiving, what side effects to watch for, and how treatment success will be measured. You might also ask about the schedule for infusions, any special precautions, and how this drug fits into your overall care plan.
Understanding Gazyva in Context
Seeing the name Gazyva or obinutuzumab does not by itself explain your diagnosis or prognosis. It is one part of a larger treatment approach tailored to your specific cancer type and health situation. Always discuss what this drug means for you personally with your healthcare provider.
Safety and Next Steps
This information is meant to help you understand what Gazyva is and how it may be used. It does not replace medical advice or decisions made by your care team. If you have questions about Gazyva in your care, the best next step is to talk with your doctor or nurse. They can explain how this drug fits into your treatment and what to expect.
Sources
Public source information used for this glossary entry includes: